Top Markets
Coin of the day
Anteris Technologies Global Corp. Anteris Technologies Global Corp.

Anteris Technologies Global Corp.

AVR
주식 순위 #10272
Anteris Technologies Global Corp. is a structural heart innovator dedicated to... Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
주가
$8.88
마지막 동기화: 2026-08-28
시가총액
$863.29M
변동 (1일)
-1.02%
변동 (1년)
120.86%
국가
US
거래 Anteris Technologies Global Corp. (AVR)

카테고리

Anteris Technologies Global Corp. (AVR)의 EPS
2026 기준 EPS TTM: 0
Anteris Technologies Global Corp.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Anteris Technologies Global Corp.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS